BREAKING
Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 12 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 12 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 12 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 12 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 13 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 13 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 13 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 13 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 14 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 14 hours ago Dogwood Therapeutics (DWTX) Q4 Loss Narrows to $0.26, Beats Estimates 12 hours ago General Mills (GIS) Q3 EPS Misses by 12% at $0.64 as Revenue Falls 8% YoY to $4.44B 12 hours ago Star Equity Holdings Slips to a Loss in Q4 FY25; Revenue Surges 69% to $56.8M 12 hours ago Ovid Therapeutics (OVID) Swings to $0.06 EPS in Q4 FY25 12 hours ago Giftify, Inc. (GIFT) Narrows Loss Q4 EPS Estimates by 11.0% 13 hours ago Weibo Corporation (WB) Misses Q4 EPS Estimates 13 hours ago ADMA CEO Adam Grossman Sells 15,000 Shares at $15.16 Amid 125K Share Insider Selloff 13 hours ago AESI CEO Forfeits Shares at $13.60 as Six-Month Insider Selling Trend Reaches 582,124 Shares 13 hours ago Ulta Beauty CEO Kecia Steelman Surrenders 1,491 Shares at $535.72 in Tax Withholding Transaction 14 hours ago BLDR CEO Peter Jackson and 7 Executives Surrender $2.77M in Shares for Tax Withholdings 14 hours ago
ADVERTISEMENT
Analysis

CNO Financial Q4 2025 Earnings: 12% EPS Growth, Record Premiums

February 6, 2026 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

Shares Surge Post-Earnings

CNO Financial Group Inc (NYSE: CNO) shares closed at $42.80. They rose 1.78% intraday after the earnings release. Meanwhile, the stock traded between $41.99 and $42.86. Over 52 weeks, shares ranged from $34.63 to $44.19. As a result, they trended positively near the upper end. Additionally, no analysts issued upgrades, downgrades, or price-target changes.

Q4 Results Shine

CNO Financial reported Q4 2025 net income of $93.0 million, or $0.95 per diluted share. This compared to $182.9 million, or $1.74 per share, last year. However, net operating income climbed to $143.4 million, or $1.47 per share. It grew from $138.0 million, or $1.31 per share—a 12% EPS increase. Furthermore, total revenues hit $1.143 billion, up from $1.097 billion. Insurance policy income reached $662.2 million, while net investment income totaled $406.1 million. Consequently, insurance product margin improved to $1.19 per share from $1.01. Non-operating items included $25.2 million in investment losses, a $9.9 million tech charge, $5.2 million in asset impairments, and a $17.3 million divested business loss. (Source: company press release and investor presentation.)

Sales and Margins Thrive

Insurance sales stayed strong. CNO achieved its 14th straight quarter of solid production. Moreover, full-year new annualized premiums (NAP) rose 15%—a record. Consumer and worksite divisions drove growth. Disciplined expenses and stable margins supported this.

Full-Year 2025 Highlights

For 2025, net income totaled $229.3 million, or $2.30 per share—down from $420.8 million, or $3.89 per share, in 2024. Yet, net operating income increased to $439.2 million, or $4.40 per share. It advanced from $429.3 million, or $3.97 per share—an 11% EPS gain. Total revenues grew to $4.487 billion from $4.449 billion. Insurance policy income hit $2.623 billion, and general account net investment income reached $1.542 billion.

Strong Capital Position

Book value per share ended at $27.92. Book value excluding comprehensive loss stood at $38.81. Return on equity measured 8.9%, while operating ROE excluding items hit 11.4%. CNO returned $386 million to shareholders via dividends and repurchases. Holding-company cash and investments totaled $351.4 million. Finally, the consolidated statutory RBC ratio reached 380%.

ADVERTISEMENT